PD-L1 siRNA,

Sristi1, Garima Gupta2, Mohammed A S Abourehab3

  • 1Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Sector 125, Noida 201301, UP, India.

概括

纳米载体增强了小干扰RNA (siRNA) 的传递,准编程死亡配体1 (PD-L1),以改善癌症免疫疗法. 这种方法可以增强抗瘤免疫力,并与其他疗法相结合时显示出潜力.